- Home
- PFE vs UBS Comparison
PFE vs UBS Comparison
Compare PFE & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFE | UBS |
|---|---|---|
| Founded | 1849 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.4B | 120.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PFE | UBS |
|---|---|---|
| Price | $25.73 | $41.69 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $28.30 | N/A |
| AVG Volume (30 Days) | ★ 57.7M | 1.8M |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | ★ 6.67% | 1.79% |
| EPS Growth | ★ 131.89 | 84.33 |
| EPS | 1.73 | ★ 2.21 |
| Revenue | ★ $62,785,000,000.00 | $48,193,000,000.00 |
| Revenue This Year | N/A | $4.87 |
| Revenue Next Year | N/A | $3.54 |
| P/E Ratio | ★ $14.93 | $17.79 |
| Revenue Growth | ★ 3.89 | 2.09 |
| 52 Week Low | $20.92 | $25.75 |
| 52 Week High | $27.69 | $42.57 |
Technical Indicators
Market Signals| Indicator | PFE | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 71.28 |
| Support Level | $25.13 | $38.33 |
| Resistance Level | $26.19 | $38.27 |
| Average True Range (ATR) | 0.54 | 0.57 |
| MACD | 0.02 | 0.45 |
| Stochastic Oscillator | 77.75 | 97.45 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.